Phase 2 clinical trial of temelimab against neuropsychiatric syndromes of Post-COVID :
Recruitment completed in November 2023;
Topline results planned for end of June 2024.
Cash position.
GeNeuro Reports 2023 Full-Year Results and Provides Corporate Update finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
27.03.2024 - Robustness of the profitable growth model confirmed Strong revenue growth, up 20%, with SaaS subscriptions up 23% at constant exchange ratesCreditPoint Software, an accretive acquisition, now fully operationalOperating profit up 58% to €5.8 million .
Robustness of the profitable growth model confirmed Strong revenue growth, up 20%, with SaaS subscriptions up 23% at constant exchange ratesCreditPoint Software, an accretive acquisition, now fully.
Sidetrade, the global leader in AI-powered Order-to-Cash applications, today announces a 20% increase in revenue for 2023 at constant exchange rates , with a surge in operating profit,.